SI1800669T1 - Orodisperzibilni farmacevtski sestavek za peroralno oromukozalno ali sublingvalno dajanje agomelatina - Google Patents

Orodisperzibilni farmacevtski sestavek za peroralno oromukozalno ali sublingvalno dajanje agomelatina

Info

Publication number
SI1800669T1
SI1800669T1 SI200630801T SI200630801T SI1800669T1 SI 1800669 T1 SI1800669 T1 SI 1800669T1 SI 200630801 T SI200630801 T SI 200630801T SI 200630801 T SI200630801 T SI 200630801T SI 1800669 T1 SI1800669 T1 SI 1800669T1
Authority
SI
Slovenia
Prior art keywords
oromucosal
agomelatine
oral
pharmaceutical composition
sublingual administration
Prior art date
Application number
SI200630801T
Other languages
English (en)
Inventor
Marc Julien
Francois Tharrault
Jean-Manuel Pean
Patrick Wuthrich
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36663148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1800669(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of SI1800669T1 publication Critical patent/SI1800669T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
SI200630801T 2005-12-14 2006-12-14 Orodisperzibilni farmacevtski sestavek za peroralno oromukozalno ali sublingvalno dajanje agomelatina SI1800669T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0512647A FR2894475B1 (fr) 2005-12-14 2005-12-14 Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
EP06291919A EP1800669B1 (fr) 2005-12-14 2006-12-14 Composition pharmaceutique orodispersible pour administration orale, oromucosale ou sublinguale d'agomelatine

Publications (1)

Publication Number Publication Date
SI1800669T1 true SI1800669T1 (sl) 2010-11-30

Family

ID=36663148

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630801T SI1800669T1 (sl) 2005-12-14 2006-12-14 Orodisperzibilni farmacevtski sestavek za peroralno oromukozalno ali sublingvalno dajanje agomelatina

Country Status (41)

Country Link
US (1) US7892575B2 (sl)
EP (1) EP1800669B1 (sl)
JP (2) JP4996225B2 (sl)
KR (3) KR20070063420A (sl)
CN (2) CN101919800A (sl)
AP (1) AP2714A (sl)
AR (1) AR058332A1 (sl)
AT (1) ATE474561T1 (sl)
AU (1) AU2006252051B2 (sl)
BR (1) BRPI0605214A (sl)
CA (1) CA2571202C (sl)
CO (1) CO5770094A1 (sl)
CR (1) CR8788A (sl)
CU (1) CU23603B7 (sl)
CY (1) CY1110824T1 (sl)
DE (1) DE602006015592D1 (sl)
DK (1) DK1800669T3 (sl)
EA (1) EA013751B1 (sl)
ES (1) ES2348994T3 (sl)
FR (1) FR2894475B1 (sl)
GE (1) GEP20084509B (sl)
GT (1) GT200600500A (sl)
HK (1) HK1101802A1 (sl)
HN (1) HN2008000874A (sl)
HR (1) HRP20100517T1 (sl)
IL (1) IL180036A0 (sl)
MA (1) MA28722B1 (sl)
MX (1) MXPA06014605A (sl)
MY (1) MY143221A (sl)
NO (1) NO20065701L (sl)
NZ (1) NZ552025A (sl)
PE (1) PE20071030A1 (sl)
PL (1) PL1800669T3 (sl)
PT (1) PT1800669E (sl)
RS (1) RS51452B (sl)
SG (1) SG133531A1 (sl)
SI (1) SI1800669T1 (sl)
TW (1) TWI327911B (sl)
UA (1) UA86622C2 (sl)
WO (1) WO2007068829A1 (sl)
ZA (1) ZA200610511B (sl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080031927A1 (en) * 2006-07-11 2008-02-07 Catani Steven J Solid oral dosage vitamin and mineral compositions
DK2238974T3 (da) 2009-04-09 2013-08-26 E Pharma Trento Spa Granulat til formulering af smeltetabletter
CN101781226B (zh) 2009-12-23 2012-03-28 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
WO2011111027A2 (en) 2010-03-11 2011-09-15 Dexcel Pharma Technologies Ltd. Oral dispersible delayed release tablet formulation
CN101836966A (zh) * 2010-05-27 2010-09-22 北京万全阳光医药科技有限公司 一种含有阿戈美拉汀的口腔崩解片
CN101991559B (zh) * 2010-11-25 2012-04-18 天津市汉康医药生物技术有限公司 一种稳定的阿戈美拉汀胶囊药物组合物
PE20140255A1 (es) * 2011-01-17 2014-03-11 Takeda Pharmaceutical Tableta dispersable en forma oral
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
JP6061924B2 (ja) 2011-10-14 2017-01-18 武田薬品工業株式会社 口腔内分散性製剤
CN103169669B (zh) * 2011-12-26 2015-06-17 中国人民解放军军事医学科学院毒物药物研究所 阿戈美拉汀包衣微丸以及可在口中分散的药物组合物
CN102552211B (zh) * 2012-02-16 2013-07-17 福建广生堂药业股份有限公司 一种阿戈美拉汀的制剂组合物及其制备方法
FR3000896B1 (fr) * 2013-01-14 2016-08-26 Philippe Perovitch Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil
FR3001894A1 (fr) * 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
PT2810656T (pt) * 2013-06-06 2017-11-13 Zentiva As Formulações de agomelatina compreendendo agomelatina na forma de cocristais
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
CN115671064A (zh) * 2014-02-07 2023-02-03 讯唐制药公司 全天然无毒舌下药物递送系统
CN104523639B (zh) * 2014-12-11 2017-03-22 扬子江药业集团四川海蓉药业有限公司 一种阿戈美拉汀片剂及其制备方法
NL2031331B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of a short-acting psychedelic compound
NL2031332B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of psychoactive compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
EP1175899B1 (fr) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granules à base d'amidon et de lactose
JP2002338500A (ja) * 2001-03-15 2002-11-27 Yamanouchi Pharmaceut Co Ltd 苦味を低減した口腔内速崩壊錠および苦み低減化方法
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
CN1981752A (zh) 2007-06-20
AP2006003844A0 (en) 2006-12-31
NO20065701L (no) 2007-06-15
ES2348994T3 (es) 2010-12-21
CO5770094A1 (es) 2007-06-29
IL180036A0 (en) 2008-01-20
FR2894475A1 (fr) 2007-06-15
AP2714A (en) 2013-07-31
SG133531A1 (en) 2007-07-30
CN101919800A (zh) 2010-12-22
CN1981752B (zh) 2011-11-02
BRPI0605214A (pt) 2007-10-09
PE20071030A1 (es) 2007-11-17
CA2571202C (fr) 2012-01-10
KR20100012858A (ko) 2010-02-08
KR20080108068A (ko) 2008-12-11
FR2894475B1 (fr) 2008-05-16
GEP20084509B (en) 2008-10-10
TWI327911B (en) 2010-08-01
WO2007068829A1 (fr) 2007-06-21
CY1110824T1 (el) 2015-06-10
UA86622C2 (ru) 2009-05-12
AU2006252051B2 (en) 2013-03-14
CR8788A (es) 2008-08-21
ATE474561T1 (de) 2010-08-15
EP1800669A1 (fr) 2007-06-27
AU2006252051A1 (en) 2007-06-28
HRP20100517T1 (hr) 2010-10-31
MA28722B1 (fr) 2007-07-02
EA013751B1 (ru) 2010-06-30
TW200738230A (en) 2007-10-16
KR20070063420A (ko) 2007-06-19
US20070134331A1 (en) 2007-06-14
AR058332A1 (es) 2008-01-30
MXPA06014605A (es) 2009-02-11
RS51452B (en) 2011-04-30
ZA200610511B (en) 2008-05-28
MY143221A (en) 2011-03-31
CU23603B7 (es) 2010-12-08
PT1800669E (pt) 2010-08-17
EA200602104A1 (ru) 2007-06-29
US7892575B2 (en) 2011-02-22
DK1800669T3 (da) 2010-10-25
DE602006015592D1 (de) 2010-09-02
GT200600500A (es) 2007-07-25
HN2008000874A (es) 2012-02-27
HK1101802A1 (en) 2007-10-26
CA2571202A1 (fr) 2007-06-14
JP4996225B2 (ja) 2012-08-08
JP2007182440A (ja) 2007-07-19
EP1800669B1 (fr) 2010-07-21
PL1800669T3 (pl) 2010-12-31
NZ552025A (en) 2008-12-24
CU20060243A7 (es) 2009-09-08
KR101013667B1 (ko) 2011-02-10
JP2012092132A (ja) 2012-05-17

Similar Documents

Publication Publication Date Title
PL1800669T3 (pl) Kompozycja farmaceutyczna, rozpraszalna w ustach, do podawania agomelatyny drogą ustną, przez błonę śluzową ust lub drogą podjęzykową
HK1197195A1 (en) Flavoring of drug-containing chewing gums
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
PL2063861T3 (pl) Jednostka dawkowania do podawania podjęzykowego, podpoliczkowego lub doustnego nierozpuszczalnych w wodzie substancji aktywnych farmaceutycznie
EP1968554A4 (en) BIOADHESIVE MEDICATION FORMULATIONS FOR ORAL TRANSMUCOSAL ADMINISTRATION
IL173571A0 (en) Injectable, oral, or topical sustained release pharmaceutical formulations
IL176519A0 (en) Directly compressible pharmaceutical composition for the oral administration of cci-779
EP1755633A4 (en) ORAL ADMINISTRATION OF PEPTIDE PHARMACEUTICAL COMPOSITIONS
HK1076743A1 (en) Orodispersible pharmaceutical composition comprising perindopril
HK1076741A1 (en) Orodispersible pharmaceutical composition comprising ivabradine
EP1941896A4 (en) COMPOSITION CONTAINING A DIPEPTIDE FOR ORAL ADMINISTRATION
ZA200708834B (en) Compositions for oral transmucosal delivery of metformin
HK1098059A1 (en) Composition comprising itraconazole for oral administration
ITMI20042356A1 (it) Composizione farmaceutica orodisperdibile e procedimento per prepararla
ZA200509741B (en) Pharmaceutical composition comprising cyclic smatostin analogues
SI1467750T1 (sl) Farmacevtski sestavek perindoprila disperzen v ustih (orodisperzen)
SI1701698T1 (sl) Neposredno stisljiv farmacevtski sestavek za peroralno dajanje CCI-779